GT Biopharma (GTBP) Return on Assets (2011 - 2026)
GT Biopharma (GTBP) posted quarterly Return on Assets of 0.06% for Q1 2026, up 31.0% year-over-year from 0.04% in Q1 2025, and up 31.13% quarter-over-quarter from 0.08% in Q4 2025.
GT Biopharma (GTBP) Return on Assets (2011 - 2026) Analysis & Trends
GT Biopharma (GTBP) has reported Return on Assets for 15 consecutive years, with 0.06% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets rose 31.0% year-over-year to 0.06%; the TTM figure through Mar 2026 stood at 0.06% (up 31.0% YoY), while the FY2025 annual figure was 0.25%, down 11.0% from the prior year.
- Return on Assets grew to 0.06% in Q1 2026 per GTBP's latest filing, from 0.08% in the prior quarter.
- Across five years, Return on Assets topped out at 0.01% in Q4 2023 and bottomed at 0.37% in Q1 2025.
- Historically, Return on Assets has averaged 0.14% across 5 years, with a median of 0.1% in 2022.
- Annual changes were most pronounced in 2025 — Return on Assets slumped 35 bps — and 2026, when it jumped 31 bps.
- GT Biopharma's Return on Assets stood at 0.2% in 2022, then soared by 96 bps to 0.01% in 2023, then tumbled by 2474 bps to 0.23% in 2024, then jumped by 64 bps to 0.08% in 2025, then surged by 31 bps to 0.06% in 2026.
- Business Quant data shows GTBP's Return on Assets at 0.06% in Q1 2026, 0.08% in Q4 2025, and 0.26% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.54 Bn | 130.69 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.89 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.84 Bn | 59.65 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.53 Bn | 51.39 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.00% |
| 10 | GT Biopharma | 8.70 Mn | 8.70 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.06% |
| Dec 31, 2025 | -0.08% |
| Sep 30, 2025 | -0.26% |
| Jun 30, 2025 | -0.30% |
| Mar 31, 2025 | -0.37% |
| Dec 31, 2024 | -0.23% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.07% |
| Jun 30, 2023 | -0.08% |
| Mar 31, 2023 | -0.20% |
| Dec 31, 2022 | -0.20% |
| Sep 30, 2022 | -0.13% |
| Jun 30, 2022 | -0.10% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |
| Mar 31, 2021 | -0.01% |
| Dec 31, 2020 | 0.01% |